Sign In to View Organizational & Contract Pricing
Select a Size
About This Item
Linear Formula:
(CH3)3SiNHCO2Si(CH3)3
CAS Number:
Molecular Weight:
205.40
Beilstein:
2043399
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Quality Level
Assay
≥98.0% (T)
form
solid
mp
77-83 °C
functional group
amine
SMILES string
C[Si](C)(C)NC(=O)O[Si](C)(C)C
InChI
1S/C7H19NO2Si2/c1-11(2,3)8-7(9)10-12(4,5)6/h1-6H3,(H,8,9)
InChI key
DGIJAZGPLFOQJE-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Other Notes
Extremely suitable reagent for the silylation of alcohols, phenols and carboxylic acids. The only by-products are CO2 and NH3; Silyloxycarbonylation of amines; Acylisocyanates from carboxylic acid chlorides
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Abi Vijenthira et al.
Blood, 136(25), 2881-2892 (2020-10-29)
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been aggregated. The objective of this study was to perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for these patients. We
Filippo Pelizzaro et al.
Cancers, 13(4) (2021-03-07)
We aimed at assessing the impact of surveillance on long-term survival in HCC patients. From the ITA.LI.CA database, we selected 1028 cases with long (≥5 years, LS group) and 2721 controls with short-term survival (<5 years, SS group). The association
Barbara Melosky et al.
The oncologist, 25(1), 64-77 (2019-05-30)
Lung cancer is one of the most common types of cancer, resulting in approximately 1.8 million deaths worldwide. Immunotherapy using checkpoint inhibitors has become standard of care in advanced non-small cell lung cancer (NSCLC), and there is increasing interest in
V.P. Kozyukov et al.
Zhur. Obshch. Khim., 51, 239-239 (1981)
Zhur. Obshch. Khim., 50, 955-955 (1980)
Articles
Results of a study involving the ability few Fluka silylating reagents to form GC-MS-compatible trimethylsilylmethyl derivatives of NSAIDs
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service